While these 21 studies all investigate FKBP5 gene polymorphisms in relation to genetic susceptibility and treatment response to depression, substantial heterogeneity exists in terms of study subjects, design, depression typing, assessment criteria, and antidepressant type. Here, FKBP5 is linked to major depressive disorder.